UB Paderborn / Katalog / Suche / in CDI

Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy

Journal of medicinal chemistry, 2021-03, Vol.64 (5), p.2576-2607

2021

Link zum Volltext

Verfügbarkeit prüfen

X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells

Proceedings of the National Academy of Sciences - PNAS, 2008-03, Vol.105 (12), p.4820-4825

2008

Link zum Volltext

Verfügbarkeit prüfen

The Phenotypic Consequences of CFTR Mutations

Annals of human genetics, 2003-09, Vol.67 (5), p.471-485

2003

Link zum Volltext

Verfügbarkeit prüfen

Systematic Variation of Pyrrolobenzodiazepine (PBD)-Dimer Payload Physicochemical Properties Impacts Efficacy and Tolerability of the Corresponding Antibody–Drug Conjugates

Journal of medicinal chemistry, 2020-09, Vol.63 (17), p.9603-9622

2020

Link zum Volltext

Verfügbarkeit prüfen

Higher order chromatin structure at the X-inactivation center via looping DNA

Developmental biology, 2008-07, Vol.319 (2), p.416-425

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification of Developmentally Specific Enhancers for Tsix in the Regulation of X Chromosome Inactivation

Molecular and Cellular Biology, 2005-04, Vol.25 (7), p.2757-2769

2005

Link zum Volltext

Verfügbarkeit prüfen

Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα)

Bioorganic & medicinal chemistry letters, 2020-02, Vol.30 (4), p.126907, Article 126907

2020

Link zum Volltext

Verfügbarkeit prüfen

A homogeneous high-DAR antibody-drug conjugate platform combining THIOMAB antibodies and XTEN polypeptides

Chemical science (Cambridge), 2022-03, Vol.13 (11), p.3147-3160

2022

Link zum Volltext

Verfügbarkeit prüfen

An Anti-CD22- seco -CBI-Dimer Antibody-Drug Conjugate (ADC) for the Treatment of Non-Hodgkin Lymphoma That Provides a Longer Duration of Response than Auristatin-Based ADCs in Preclinical Models

Molecular cancer therapeutics, 2021-02, Vol.20 (2), p.340-346

2021

Link zum Volltext

Verfügbarkeit prüfen

Mapping of DNA Replication Origins to Noncoding Genes of the X-Inactivation Center

Molecular and Cellular Biology, 2006-05, Vol.26 (10), p.3707-3717

2006

Link zum Volltext

Verfügbarkeit prüfen

Antibody–Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In Vivo

Bioconjugate chemistry, 2019-05, Vol.30 (5), p.1356-1370

2019

Link zum Volltext

Verfügbarkeit prüfen

Conjugation of Indoles to Antibodies through a Novel Self‐Immolating Linker

Chemistry : a European journal, 2018-04, Vol.24 (19), p.4830-4834

2018

Link zum Volltext

Verfügbarkeit prüfen

Direct Tie2 Agonists Stabilize Vasculature for the Treatment of Diabetic Macular Edema

Translational vision science & technology, 2022-10, Vol.11 (10), p.27-27

2022

Link zum Volltext

Verfügbarkeit prüfen

Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery

Regenerative medicine, 2010-07, Vol.5 (4), p.557-568

2010

Link zum Volltext

Verfügbarkeit prüfen

Morphological restriction of human coronary artery endothelial cells substantially impacts global gene expression patterns

The FEBS journal, 2013-09, Vol.280 (18), p.4474-4494

2013

Link zum Volltext

Verfügbarkeit prüfen

Gene expression analysis reveals marked differences in the transcriptome of infantile hemangioma endothelial cells compared to normal dermal microvascular endothelial cells

Vascular cell, 2013-03, Vol.5 (1), p.6-6

2013

Link zum Volltext

Verfügbarkeit prüfen

An element in intron 1 of the CFTR gene augments intestinal expression in vivo

Human molecular genetics, 2001-07, Vol.10 (14), p.1455-1464

2001

Link zum Volltext

Verfügbarkeit prüfen

Abstract P167: Site-specific Dolasynthen ADCs demonstrate consistent exposure across a wide range of drug-to-antibody ratios

Molecular cancer therapeutics, 2021-12, Vol.20 (12_Supplement), p.P167-P167

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy

Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 1: Exploration of Antibody Linker, Payload Loading, and Payload Molecular Properties

X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells

The Phenotypic Consequences of CFTR Mutations

Systematic Variation of Pyrrolobenzodiazepine (PBD)-Dimer Payload Physicochemical Properties Impacts Efficacy and Tolerability of the Corresponding Antibody–Drug Conjugates

Higher order chromatin structure at the X-inactivation center via looping DNA

Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response

LRRC15 + myofibroblasts dictate the stromal setpoint to suppress tumour immunity

Identification of Developmentally Specific Enhancers for Tsix in the Regulation of X Chromosome Inactivation

Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity

Antibody-mediated delivery of chimeric protein degraders which target estrogen receptor alpha (ERα)

A homogeneous high-DAR antibody-drug conjugate platform combining THIOMAB antibodies and XTEN polypeptides

An Anti-CD22- seco -CBI-Dimer Antibody-Drug Conjugate (ADC) for the Treatment of Non-Hodgkin Lymphoma That Provides a Longer Duration of Response than Auristatin-Based ADCs in Preclinical Models

Mapping of DNA Replication Origins to Noncoding Genes of the X-Inactivation Center

Antibody–Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In Vivo

Conjugation of Indoles to Antibodies through a Novel Self‐Immolating Linker

Exploration of Pyrrolobenzodiazepine (PBD)-Dimers Containing Disulfide-Based Prodrugs as Payloads for Antibody–Drug Conjugates

Direct Tie2 Agonists Stabilize Vasculature for the Treatment of Diabetic Macular Edema

Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery

Morphological restriction of human coronary artery endothelial cells substantially impacts global gene expression patterns

Gene expression analysis reveals marked differences in the transcriptome of infantile hemangioma endothelial cells compared to normal dermal microvascular endothelial cells

An element in intron 1 of the CFTR gene augments intestinal expression in vivo

Abstract P167: Site-specific Dolasynthen ADCs demonstrate consistent exposure across a wide range of drug-to-antibody ratios

Front Cover: Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity (ChemMedChem 1/2020)

Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response

Suchergebnisse filtern